Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Short-term Structured Exercise Training Program Plus Diet Intervention in Patients With Polycystic Ovary Syndrome (PCOS)

This study has been completed.
Information provided by:
University Magna Graecia Identifier:
First received: July 15, 2009
Last updated: November 2, 2010
Last verified: November 2009
Clomiphene citrate (CC) is the first-line therapy for infertile women with polycystic ovary syndrome (PCOS). Unfortunately, at least 20% of PCOS results are not responsive to CC. Structured exercise training (SET) and diet has been successfully employed to restore ovarian function and to improve reproductive outcomes in obese and overweight women with PCOS. The current study was aimed to test the hypothesis that a short-term SET program plus diet intervention can improve the ovarian response to CC in CC-resistant PCOS patients.

Condition Intervention Phase
Polycystic Ovary Syndrome
Other: SET-diet plus clomiphene
Drug: Clomiphene citrate
Behavioral: Structured exercise program plus hypocaloric diet
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Does Short-term Structured Exercise Training Program Plus Diet Intervention Improve Ovarian Sensitivity to Clomiphene Citrate in Polycystic Ovary Syndrome Patients (PCOS)? A Prospective Randomized Controlled Study

Resource links provided by NLM:

Further study details as provided by University Magna Graecia:

Primary Outcome Measures:
  • Ovulation rate [ Time Frame: three months ]

Secondary Outcome Measures:
  • Clinical data [ Time Frame: three months ]
  • Metabolic data [ Time Frame: three months ]

Enrollment: 96
Study Start Date: February 2008
Study Completion Date: October 2009
Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: SET-diet plus clomiphene
Structured exercise program plus hypocaloric diet for two months and received one-cycle of clomiphene citrate for one cycle
Other: SET-diet plus clomiphene
Two months of structured exercise program plus hypocaloric diet followed by 150 mg daily of clomiphene citrate
Other Names:
  • Lifestyle modification
  • CC
Active Comparator: Clomiphene citrate
One month of observation followed by one-cycle of clomiphene citrate therapy
Drug: Clomiphene citrate
Clomiphene citrate at 150 mg daily for one cycle
Other Name: CC
Experimental: SET plus diet
Lifestyle modifications for two months.
Behavioral: Structured exercise program plus hypocaloric diet
SET plus diet
Other Name: Lifestyle modifications

Detailed Description:
Ninety-six PCOS patients considered CC-resistant because not responsive to 150 mg daily of CC were randomized in three arms (group A, B, and C). Group A underwent SET program plus hypocaloric diet for two months, group B had one month of observation followed by one-cycle of CC therapy, and group C underwent SET program plus hypocaloric diet for two months and received one-cycle of CC for one cycle. CC was always given at the maximal dose previously used. Clinical, hormonal and metabolic data were assessed at baseline and after intervention. Ovulation was monitored by ultrasound and confirmed by plasma progesterone assay.

Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • PCOS
  • Anovulation

Exclusion Criteria:

  • Major Medical Condition
  • Severe Obesity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01004068

"Pugliese" Hospital
Catanzaro, Italy, 88100
Sponsors and Collaborators
University Magna Graecia
Principal Investigator: Stefano Palomba, MD University Magna Graecia
  More Information

Responsible Party: Department of Obstetrics and Gynecology, University Magna Graecia of Catanzaro Identifier: NCT01004068     History of Changes
Other Study ID Numbers: 06/2009
Study First Received: July 15, 2009
Last Updated: November 2, 2010

Keywords provided by University Magna Graecia:
Physical activity

Additional relevant MeSH terms:
Polycystic Ovary Syndrome
Pathologic Processes
Ovarian Cysts
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases
Citric Acid
Calcium Chelating Agents
Chelating Agents
Sequestering Agents
Molecular Mechanisms of Pharmacological Action
Estrogen Antagonists
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Fertility Agents, Female
Fertility Agents
Reproductive Control Agents
Selective Estrogen Receptor Modulators processed this record on May 22, 2017